CAM
ABMD

ClariVest Asset Management’s Abiomed Inc ABMD Stock Holding History

ClariVest Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,700
Closed -$1.53M – 799
2018
Q4 		$1.53M Hold
4,700
– – 0.03% 341
2018
Q3 		$2.11M Hold
4,700
– – 0.04% 320
2018
Q2 		$1.92M Buy
+4,700
New +$1.7M 0.03% 351
2016
Q4 		– Sell
-11,912
Closed -$1.53M – 740
2016
Q3 		$1.53M Hold
11,912
– – 0.04% 245
2016
Q2 		$1.3M Buy
11,912
+1,600
+16% +$159K 0.04% 267
2016
Q1 		$978K Buy
+10,312
New +$870K 0.03% 290

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ClariVest Asset Management's ABMD Position: Q1 2019 in Review

ClariVest Asset Management sold out of Abiomed Inc (ABMD) in Q1 2019, closing a stake of 4,700 shares — an estimated $1.53M sold.

ClariVest Asset Management first reported a position in ABMD in Q1 2016 and held it in 6 quarters. The position peaked at $2.11M in Q3 2018. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

  • ClariVest Asset Management reported no remaining Abiomed Inc position as of Q1 2019 after selling out during the quarter.
  • ClariVest Asset Management sold 4,700 Abiomed Inc shares in Q1 2019, an estimated $1.53M.
  • ClariVest Asset Management first reported a position in Abiomed Inc in Q1 2016 and held it in 6 quarters.
  • ClariVest Asset Management's Abiomed Inc position peaked at $2.11M in Q3 2018.
  • 559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on ClariVest Asset Management's 13F filing for Q1 2019, filed 13 May 2019.